Cullen Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $228M | Buy |
2,630,944
+135,738
| +5% | +$13M | 2.34% | 13 |
|
|
2025
Q4 | $240M | Sell |
2,495,206
-177,169
| -7% | -$17.2M | 2.62% | 9 |
|
|
2025
Q3 | $255M | Sell |
2,672,375
-29,045
| -1% | -$2.67M | 2.78% | 5 |
|
|
2025
Q2 | $235M | Sell |
2,701,420
-19,459
| -0.7% | -$1.65M | 2.68% | 6 |
|
|
2025
Q1 | $244M | Buy |
2,720,879
+163,320
| +6% | +$14.6M | 2.82% | 5 |
|
|
2024
Q4 | $204M | Sell |
2,557,559
-178,010
| -7% | -$15.4M | 2.38% | 15 |
|
|
2024
Q3 | $246M | Buy |
2,735,569
+121,744
| +5% | +$10.2M | 2.68% | 9 |
|
|
2024
Q2 | $206M | Sell |
2,613,825
-90,965
| -3% | -$7.46M | 2.37% | 13 |
|
|
2024
Q1 | $236M | Buy |
2,704,790
+643,941
| +31% | +$55M | 2.62% | 11 |
|
|
2023
Q4 | $170M | Sell |
2,060,849
-878,480
| -30% | -$67M | 2.52% | 12 |
|
|
2023
Q3 | $230M | Sell |
2,939,329
-107,821
| -4% | -$9.03M | 2.69% | 10 |
|
|
2023
Q2 | $268M | Buy |
3,047,150
+28,277
| +0.9% | +$2.43M | 2.4% | 7 |
|
|
2023
Q1 | $243M | Buy |
+3,018,873
| New | +$246M | 2.23% | 13 |
|
|
2022
Q4 | – | Sell |
-2,626,885
| Closed | -$212M | – | 220 |
|
|
2022
Q3 | $212M | Buy |
2,626,885
+579,025
| +28% | +$52M | 2.27% | 12 |
|
|
2022
Q2 | $184M | Sell |
2,047,860
-103,147
| -5% | -$10.5M | 1.85% | 18 |
|
|
2022
Q1 | $239M | Buy |
2,151,007
+394,203
| +22% | +$41.6M | 2.2% | 11 |
|
|
2021
Q4 | $182M | Buy |
1,756,804
+47,602
| +3% | +$5.51M | 1.7% | 24 |
|
|
2021
Q3 | $214M | Buy |
1,709,202
+140,941
| +9% | +$18.2M | 2.1% | 13 |
|
|
2021
Q2 | $195M | Buy |
1,568,261
+63,894
| +4% | +$8.02M | 1.88% | 18 |
|
|
2021
Q1 | $178M | Buy |
1,504,367
+1,128,561
| +300% | +$132M | 1.92% | 19 |
|
|
2020
Q4 | $44M | Sell |
375,806
-7,909
| -2% | -$871K | 2.44% | 14 |
|
|
2020
Q3 | $39.9M | Buy |
383,715
+148,917
| +63% | +$15M | 2.31% | 17 |
|
|
2020
Q2 | $21.5M | Buy |
234,798
+1,729
| +0.7% | +$166K | 1.21% | 33 |
|
|
2020
Q1 | $21M | Buy |
233,069
+223,759
| +2,403% | +$23.8M | 1.21% | 36 |
|
|
2019
Q4 | $1.06M | Sell |
9,310
-2,400
| -20% | -$263K | 0.04% | 90 |
|
|
2019
Q3 | $1.27M | Sell |
11,710
-2,900
| -20% | -$303K | 0.05% | 88 |
|
|
2019
Q2 | $1.42M | Sell |
14,610
-1,870
| -11% | -$171K | 0.06% | 96 |
|
|
2019
Q1 | $1.5M | Buy |
16,480
+1,960
| +13% | +$175K | 0.06% | 88 |
|
|
2018
Q4 | $1.32M | Hold |
14,520
| – | – | 0.06% | 90 |
|
|
2018
Q3 | $1.43M | Sell |
14,520
-5,500
| -27% | -$508K | 0.05% | 93 |
|
|
2018
Q2 | $1.71M | Hold |
20,020
| – | – | 0.06% | 97 |
|
|
2018
Q1 | $1.61M | Buy |
20,020
+4,640
| +30% | +$383K | 0.06% | 103 |
|
|
2017
Q4 | $1.24M | Buy |
15,380
+3,720
| +32% | +$298K | 0.04% | 108 |
|
|
2017
Q3 | $907K | Hold |
11,660
| – | – | 0.03% | 111 |
|
|
2017
Q2 | $1.03M | Hold |
11,660
| – | – | 0.04% | 109 |
|
|
2017
Q1 | $939K | Hold |
11,660
| – | – | 0.03% | 111 |
|
|
2016
Q4 | $831K | Hold |
11,660
| – | – | 0.03% | 126 |
|
|
2016
Q3 | $1.01M | Hold |
11,660
| – | – | 0.03% | 120 |
|
|
2016
Q2 | $1.01M | Hold |
11,660
| – | – | 0.04% | 115 |
|
|
2016
Q1 | $875K | Hold |
11,660
| – | – | 0.03% | 124 |
|
|
2015
Q4 | $897K | Hold |
11,660
| – | – | 0.03% | 126 |
|
|
2015
Q3 | $781K | Hold |
11,660
| – | – | 0.03% | 128 |
|
|
2015
Q2 | $864K | Hold |
11,660
| – | – | 0.03% | 134 |
|
|
2015
Q1 | $909K | Sell |
11,660
-1,590
| -12% | -$121K | 0.03% | 128 |
|
|
2014
Q4 | $957K | Hold |
13,250
| – | – | 0.03% | 125 |
|
|
2014
Q3 | $821K | Hold |
13,250
| – | – | 0.02% | 133 |
|
|
2014
Q2 | $845K | Hold |
13,250
| – | – | 0.02% | 147 |
|
|
2014
Q1 | $815K | Hold |
13,250
| – | – | 0.02% | 140 |
|
|
2013
Q4 | $760K | Hold |
13,250
| – | – | 0.02% | 125 |
|
|
2013
Q3 | $706K | Hold |
13,250
| – | – | 0.02% | 124 |
|
|
2013
Q2 | $682K | Buy |
+13,250
| New | +$655K | 0.02% | 101 |
|
Other funds holding MDT
VCM
VPM
Cullen Capital Management's MDT Position: Q1 2026 in Review
Cullen Capital Management increased its Medtronic (MDT) stake by 5.4% in Q1 2026, buying an estimated $13M and bringing the position to 2,630,944 shares worth $228M. The position accounts for 2.34% of the portfolio, ranked #13.
Cullen Capital Management first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $268M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Cullen Capital Management held 2,630,944 shares of Medtronic worth $228M as of Q1 2026.
- Cullen Capital Management bought 135,738 Medtronic shares in Q1 2026, an estimated $13M.
- Medtronic made up 2.34% of Cullen Capital Management's portfolio in Q1 2026, its #13 holding.
- Cullen Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
- Cullen Capital Management's Medtronic position peaked at $268M in Q2 2023.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Cullen Capital Management's 13F filing for Q1 2026, filed 15 May 2026.